Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

61.74 +1.51 (+2.51%)

Streaming Delayed Price Updated: 11:41 AM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

43 44 Next >

Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More ↗

February 14, 2025

Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.

Via Benzinga

DexCom (DXCM) Q4 2024 Earnings Call Transcript ↗

February 13, 2025

DXCM earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

DexCom: Revenue Up, EPS Misses Mark ↗

February 13, 2025

DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.

Via The Motley Fool

DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue

February 13, 2025

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s...

Via StockStory

Topics Artificial Intelligence

Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations ↗

February 13, 2025

Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share.

Via Investor's Business Daily

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

Should You Buy DexCom Stock Before Feb. 13? ↗

February 06, 2025

Via The Motley Fool

Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings) ↗

February 03, 2025

Via Benzinga

Expert Outlook: DexCom Through The Eyes Of 11 Analysts ↗

January 16, 2025

Via Benzinga

Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results

February 13, 2025

From DexCom, Inc.

Via Business Wire

DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect

February 12, 2025

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.

Via StockStory

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

February 10, 2025

Based on a technical and fundamental analysis of NASDAQ:DXCM we can say: DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade ↗

February 03, 2025

Via The Motley Fool

Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years ↗

February 03, 2025

Via The Motley Fool

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

January 16, 2025

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

NASDAQ:DXCM qualifies as a high growth stock and is consolidating. ↗

December 25, 2024

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

1 Reason to Sell DexCom Stock, and 1 Reason to Buy ↗

December 21, 2024

Via The Motley Fool

For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering. ↗

January 31, 2025

NASDAQ:DXCM is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.

Via Chartmill

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

January 30, 2025

From DexCom, Inc.

Via Business Wire

Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday ↗

January 16, 2025

Via Benzinga

This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

January 16, 2025

Via Benzinga

Peering Into DexCom's Recent Short Interest ↗

December 16, 2024

Via Benzinga

2 Healthcare Stocks to Buy Hand Over Fist in January ↗

January 16, 2025

Via The Motley Fool

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook

January 13, 2025

From DexCom, Inc.

Via Business Wire

Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market. ↗

January 09, 2025

Smart rings are one of the hottest consumer electronics categories, as evidenced by exhibitors at CES 2025. Oura leads the market.

Via Investor's Business Daily

3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025 ↗

January 08, 2025

Via The Motley Fool

Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From DexCom, Inc.

Via Business Wire

These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024 ↗

January 04, 2025

Via The Motley Fool

DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM

December 21, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

December 17, 2024

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions